employer glp-1 coverage news Your Weight-Loss Drugs Are Next on the Corporate Chopping Block glp-1 news employers The Growing

CrossRef Live zoster vaccination and hepatobiliary risk reduction: a nationwide South Korean study Junyeol Kim, Kyeongmin Lee, Jiyeon Oh, Hayeon Lee, Jong-In Chang, Tae Young Park, Dong Keon Yon, Hyoung-Chul Oh The Korean Journal of Internal Medicine .2025

However, uptake transporter assays indicated that ATSP-7041 acts as both a substrate for OATPs and a potent inhibitor of OATP1B1 (IC 50 : 0.81 M), suggesting the potential for clinically relevant DDIs

Du X, Zhang H, Zhang W, Wang Q, Wang W, Ge G, et al

Third, although the notion of enhancing healthspan and potentially prolonging lifespan through GLP-1 RA treatment is appealing, its application to asymptomatic individuals in clinical settings is still primarily theoretical and lacks robust empirical support at this time

If left unaddressed, these can eventually put you at risk for malnutrition and sarcopenia, or loss of your lean body mass